Bend Bioscience (formed from CoreRx, Societal CDMO, and other specialist CDMOs) is a U.S.-based small molecule pharmaceutical CDMO offering end-to-end development and manufacturing from pre-clinical to commercial scale. They specialize in oral bioavailability enhancement via spray dried dispersions, particle engineering, multiparticulates, and modified release technologies. They operate FDA, EMA, ANVISA, and DEA-inspected facilities across three U.S. locations (Oregon, Georgia, Florida) with capabilities spanning oral solids, liquids, topicals, and powders for inhalation.
spray drying, amorphous solid dispersions, oral bioavailability enhancement, modified release, multiparticulates, particle engineering, potent compound handling, technology transfer
1 site worldwide
Involvement in 1 clinical trial
No reviews available yet.
No documents available.